Bondable anti-adhesion membrane and preparation method thereof

Through the blending or electrospinning technology of fully synthesized adhesive and polyester, a dense structure of anti-adhesion film is formed, which solves the problems of unstable and non-adhesion structure of the existing anti-adhesion film, and realizes the pericardial, tendon and other parts Effective anti-adhesion effect and safety.

CN118976164APending Publication Date: 2024-11-19SHANGHAI DIVINE MEDICAL TECH
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411013050.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-26
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The existing anti-adhesion film is unstable in the body, and it is difficult to maintain integrity for a long time, and it is impossible to effectively prevent blood vessels from entering. Moreover, the fully synthetic anti-adhesion film has no tissue adhesion, polysaccharide products degrade too quickly, and there is a risk of allergies, making it difficult to be in the pericardium. , tendons and other parts have an anti-adhesion effect.

Method used

Using a composite structure of an adhesive layer and a barrier layer formed by blending or coaxial electrospinning of fully synthetic adhesive and fully synthetic polyester, the barrier layer of a dense structure prevents blood vessels from growing in, the adhesive layer provides adhesive strength, polycarboxylic Acid synthetic glue is used for tissue bonding, avoiding fiber layer layering, and using different solvent combinations and conductivity substrates to achieve a more controlled degradation cycle.

Benefits of technology

It realizes the structural retention of the anti-adhesion membrane in the body for a longer period of time, provides better anti-adhesion effect, avoids allergic reactions, and is suitable for areas that require a longer healing time, ensuring that the transmission of nutrients is not hindered, and strengthens the machinery. Strength and safety performance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118976164A_ABST
    Figure CN118976164A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of biomedical materials. The invention provides a bondable anti-adhesion membrane which comprises a composite structure composed of a bonding layer and a barrier layer, the bonding layer is formed by blending or coaxial electrostatic spinning of a total synthesis adhesive and total synthesis polyester, and the barrier layer is formed by electrostatic spinning of total synthesis polyester; the total synthetic polyester is at least one of polylactic acid (PLA) and polylactic acid-glycolic acid copolymer (PLGA), the total synthetic adhesive is polycarboxylic acid synthetic adhesive, and the invention also provides a preparation method of the adhesive anti-adhesion membrane. The barrier layer has the structural characteristics of a compact structure and a porous structure, blood vessels can be well prevented from growing into the barrier layer, transmission of nutrient substances is not hindered, the compact structure cannot be layered, degradation is uniform, and the barrier layer can be kept for a long time in vivo in a complete structure; the bonding layer can provide enough bonding strength to ensure that the anti-adhesion membrane stably stays at an application part; the bonding layer is tightly combined with the barrier layer, so that the condition of layering between fiber layers is avoided, and the anti-adhesion effect on parts, such as pericardium, tendon and the like, needing longer repair time is better exerted.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of biomedical materials, and in particular to an absorbable anti-adhesion membrane for in vivo implantation and a preparation method thereof. Background Art

[0002] Postoperative adhesion is one of the important medical problems that has not been solved in the field of surgery at home and abroad. Local adhesion can lead to a variety of serious complications, such as intestinal obstruction, chronic abdominal pain and female infertility, affecting the effect of surgery and the quality of life of patients, and increasing the mental and economic burden on patients. In addition, pericardial adhesion may lead to the risk of fatal massive bleeding during reoperation, and the mortality rate caused by massive bleeding is as high as 37%. In order to prevent adhesion or reduce the severity of adhesion, surgical anti-adhesion products are indispensable.

[0003] Adhesion is the result of tissue repair after injury. When there is local injury, the dynamic balance between fibrin deposition and the fibrinolytic system is broken, and fibrin deposition becomes dominant, forming early adhesion. Fibrocytes and blood vessels invade, local vascularization occurs, and permanent adhesion is formed. Blood vessel growth is an important component of fibrous adhesion bands. Early adhesion caused by fibrin deposition can be cleared after the fibrinolytic system resumes its function, while blood vessel growth provides nutrients and oxygen to the healing area, which promotes the formation and consolidation of adhesion. The scar structure finally formed will exist for a long time, so the anti-adhesion barrier needs to be able to prevent blood vessel growth.

[0004] The Chinese patent with announcement number CN106730047A provides a hemostatic and anti-adhesion membrane and its preparation method. The anionic starch hemostatic material is attached to the outer layer of the anti-adhesion fiber layer formed by interweaving degradable polymer materials. It can quickly absorb the moisture in the blood to form a gel-like mixture that can adhere to the wound surface. Its loose structure makes it difficult to maintain structural integrity for a long time in the body, and it is difficult to exert an anti-adhesion effect on parts such as the pericardium and tendons that require a long repair time.

[0005] The Chinese patent with announcement number CN102908658A provides an electrospun polymer anti-adhesion fiber membrane with good flexibility, in which PLGA and polymer softener are electrostatically prepared into a fiber membrane by electrostatic spinning. The above patented anti-adhesion membrane has no tissue adhesion, and if it needs to be fixed to the injured part, it needs to be sutured, causing additional damage.

[0006] Currently, most of the fully synthetic anti-adhesion films used in clinical practice are prepared by electrospinning. The existing electrospinning process has its limitations. The products prepared by it cannot control their structure, and are mostly fluffy, easy to delaminate, and unevenly degraded. Although it has a long degradation cycle, its structural integrity is short-lived, and it is difficult to maintain its structural integrity for a long time. Vascular adhesion may occur in 3-21 days, and fully synthetic anti-adhesion films have no tissue adhesion. Other polysaccharide anti-adhesion products have tissue adhesion but degrade too quickly. They have poor anti-adhesion effects on areas that require a long healing time, such as the pericardium and tendons, and there is a risk of allergies.

[0007] Therefore, the problem to be solved by the present invention is to make the anti-adhesion material have a longer intact structure retention time, be able to effectively prevent blood vessels from growing without hindering the transmission of nutrients, and better exert its anti-adhesion effect on parts such as the pericardium and tendons that require a longer repair time. Summary of the invention

[0008] In order to solve the problem of insufficient anti-adhesion products mentioned above, the present invention provides an adhesive anti-adhesion membrane and a preparation method thereof. The adhesive anti-adhesion membrane prepared by the present invention has a dense structure and a longer retention time of the intact structure. Its in vitro degradation performance is tested by pH 7.4 phosphate buffer. Except for a small amount of floccules at 28 days, the structure is intact. It can be applied to areas such as the pericardium and tendons that require a longer healing time, and has adhesive properties and excellent safety performance.

[0009] The object of the present invention is to provide a bondable anti-adhesion film, comprising a composite structure consisting of an adhesive layer and a barrier layer, wherein the adhesive layer is formed by blending or coaxial electrospinning of a fully synthetic adhesive and a fully synthetic polyester, and the barrier layer is formed by electrospinning of a fully synthetic polyester;

[0010] The fully synthetic polyester is at least one of polylactic acid PLA and polylactic acid-glycolic acid copolymer PLGA, and the fully synthetic adhesive is polycarboxylic acid synthetic adhesive.

[0011] The adhesive layer and the barrier layer of the present invention are both made of fully synthetic materials. The dense and porous structures of the barrier layer can effectively prevent blood vessels from growing in and avoid adhesion, and do not hinder the transmission of nutrients. The dense structure of the barrier layer will not be stratified and degrades evenly, and can be maintained in the body with a complete structure for a long time. The adhesive layer can provide sufficient adhesive strength to ensure that the anti-adhesion film stays firmly at the application site. The adhesive layer is tightly combined with the barrier layer to avoid stratification between fiber layers.

[0012] Furthermore, the thickness of the adhesive anti-adhesion film is 0.04-0.15 mm, the average pore size is 10-50 μm, the thickness of the adhesive layer is 0.001-0.05 mm, the mass ratio of the fully synthetic adhesive to the fully synthetic polyester is 1:5-40, and the shear bonding force of the adhesive layer is greater than 300 gf.

[0013] Furthermore, the polylactic acid PLA or polylactic acid-glycolic acid copolymer PLGA has a molecular weight of 2×10 4 —2×10 5 The molecular weight and hydrophilicity can be adjusted by different initiators. The molecular weight is between 20,000 and 200,000, and one or more different molecular weight polyesters can be used alone or in combination. Different parts have different degradation times. For example, the abdominal cavity can be prevented from adhesion within 5 days, and the tendons and other parts that require lubrication properties can choose hydrophilic copolymers.

[0014] Furthermore, the polycarboxylic acid synthetic rubber has a molecular structure with acrylic acid and N-vinyl pyrrolidone as the main chain and grafted NHS ester, the molar ratio of acrylic acid to N-vinyl pyrrolidone is 0.3-3:1, the molar ratio of NHS ester to acrylic acid is 1:1-5, and the molecular weight of the polycarboxylic acid synthetic rubber is 10 5 -3×10 5 Under physiological conditions, NHS ester reacts with tissue protein, and the polycarboxylic acid synthetic glue used in the present invention has excellent safety performance and tissue adhesion performance.

[0015] The present invention also provides a method for preparing a bondable anti-adhesion film, comprising the following steps:

[0016] (1) mixing the first solvent with the fully synthetic polyester to obtain a fully synthetic polyester solution having a concentration of 0.12-0.24 kg / L;

[0017] (2) mixing the second solvent with the fully synthetic adhesive and the fully synthetic polyester, respectively, to obtain a fully synthetic adhesive solution with a concentration of 0.06-0.12 kg / L and a fully synthetic polyester solution with a concentration of 0.12-0.24 kg / L;

[0018] (3) electrospinning the fully synthetic adhesive solution and the fully synthetic polyester solution prepared in step (2) on a receiving substrate in a blended or coaxial form to form an adhesive layer;

[0019] (4) spinning the fully synthetic polyester solution prepared in step (1) onto the adhesive layer by electrospinning to form a barrier layer, thereby obtaining an adhesive anti-adhesion film;

[0020] Wherein, when the first solvent in step (1) is a single solvent, the volume resistivity of the receiving substrate in step (3) is less than 10 12Ω·cm.

[0021] Furthermore, the first solvent is at least one of methyl formate, ethyl acetate, methyl acetate, dimethyl carbonate, dimethyltetrahydrofuran, acetone, and methanol.

[0022] Furthermore, the second solvent is a mixed solvent formed by mixing any one of methanol and acetone with dichloromethane in a volume ratio of 2:17-21.

[0023] The invention has a simple preparation process and a compact structure. The barrier layer is prepared by using a combination of different solvents for the fully synthetic polyester solution, or by using a receiving substrate having a volume resistivity of less than 10 12 The anti-adhesion membrane structure is dense and has a longer retention time of intact structure. The adhesive layer and barrier layer are tightly combined to avoid stratification between fiber layers. Its in vitro degradation performance is tested by pH 7.4 phosphate buffer. Except for a small amount of floccules at 28 days, the structure is intact and can be applied to the pericardium, tendons and other parts that require a longer healing time.

[0024] Furthermore, in the electrospinning step in step (3), the flow rate of the fully synthetic adhesive solution is 15-40 mL / h, the flow rate of the fully synthetic polyester solution is 5-30 mL / h, an electric field voltage of -20-20 kV is applied, and spinning is performed for 1-10 min.

[0025] Furthermore, in the electrospinning step in step (4), the fully synthetic polyester solution has a push rate of 10-40 mL / h, an electric field voltage of -20-20 kV is applied, and the spinning is performed for 5-40 min.

[0026] Furthermore, the receiving substrate is a substrate having patterns with different electrical conductivity.

[0027] The fiber membrane with special texture is achieved by spinning with substrates with different conductivity patterns, which is used to distinguish functional structures. In the above steps, the receiving substrate can be customized. Print and apply textures on release paper, release film and other substrates before silicon coating with antistatic agent or metal powder, carbon powder, PET, PTFE and other materials. Dense / loose and identifiable textures can be obtained on this substrate through electrospinning. The pore size of this area is consistent with the pore size of the main area, and there is no obvious distinction between thickness and thinness.

[0028] Compared with the prior art, the present invention has the following beneficial effects:

[0029] (1) The adhesive layer and the barrier layer of the present invention are all made of fully synthetic materials. The barrier layer has the structural characteristics of a dense structure and a porous structure, which can effectively prevent blood vessels from growing in and does not hinder the transmission of nutrients. The dense structure will not be delaminated and degrades evenly, and can be maintained in the body with a complete structure for a long time; the adhesive layer can provide sufficient bonding strength to ensure that the anti-adhesion membrane stays firmly at the application site; the adhesive layer is tightly combined with the barrier layer to avoid stratification between fiber layers. The in vitro degradation performance is tested by pH 7.4 phosphate buffer. Except for a small amount of flocculent after 28 days, the structure is intact, and it can be applied to the pericardium, tendons and other sites that require a long healing time;

[0030] (2) The preparation process of the anti-adhesion film is simple, and its dense structure is made of a combination of different solvents for the fully synthetic polyester solution used in the barrier layer, or a volume resistivity of less than 10 12 Ω·cm substrate, so that the anti-adhesion membrane has a more controllable degradation cycle, and its complete structure is retained in the body for a longer time;

[0031] (3) The prepared anti-adhesion membrane has a dense structure. It not only has higher mechanical strength than the general electrospun membrane, but also has a longer intact structure retention time. The adhesive layer can provide initial adhesion, so that the anti-adhesion membrane is tightly attached to the wound and its surrounding tissues, avoiding the movement of the barrier layer and affecting the postoperative anti-adhesion effect, providing a better anti-adhesion effect, and can take into account the pericardium, tendons and other parts that require a longer healing time;

[0032] (4) The polycarboxylic acid synthetic glue used in the present invention has excellent safety and tissue adhesion properties, avoiding the existing polysaccharide materials with tissue adhesion properties that degrade too quickly and cause adverse reactions such as allergies. The anti-adhesion membrane has an anti-adhesion mechanism that prevents blood vessels from growing into the membrane to avoid the formation of permanent adhesions such as scar tissue that it promotes. The method for preparing a dense structure film provided by the present invention opens up more possibilities for the electrospinning process and its related fields. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 Schematic diagram of the anti-adhesion membrane structure.

[0034] In the figure: 1. Barrier layer; 2. Adhesive layer. DETAILED DESCRIPTION

[0035] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0036] Example 1

[0037] Step 1: dissolve polylactic acid-glycolic acid copolymer (molecular weight 150000) in a solvent of dimethyl carbonate, methyl acetate and acetone in a volume ratio of 1:1:2 to a concentration of 0.16 kg / L, stir and mix for later use;

[0038] Step 2: Polylactic acid-co-glycolic acid (molecular weight 150,000) and polycarboxylic acid synthetic rubber (molecular weight 100,000-300,000) are dissolved in a solution of methanol and dichloromethane in a volume ratio of 2:19, with concentrations of 0.16 kg / L and 0.12 kg / L, respectively, and stirred and mixed for later use;

[0039] Step 3: Use conventional release paper as the receiving substrate to load the solutions obtained in step 2 into syringes respectively, connect them to the coaxial needle using a capillary tube, push the polycarboxylic acid synthetic rubber at a flow rate of 18 mL / h, and push the polylactic acid-glycolic acid copolymer at a flow rate of 24 mL / h, apply an electric field voltage of -20-20 kV, and spin for 2 min;

[0040] Step 4: Put the polylactic acid-co-glycolic acid solution obtained in step 1 into a syringe, connect it to the injection needle using a capillary, arrange the needles symmetrically in 4 groups, apply an electric field voltage of -20-20 kV at 20 mL / h, and spin for 20 minutes.

[0041] Step 5: Dry and cut the film to make it into a finished anti-adhesion film. Figure 1 shown.

[0042] In the present application, a fully synthetic adhesive and a fully synthetic polyester mixed structure are spun on a substrate by electrostatic spinning, and then the fully synthetic polyester is spun on the upper layer. The fully synthetic adhesive and the fully synthetic polyester mixed structure are prepared in a blended or coaxial form. Since the anti-adhesion film has an adhesive layer and a barrier layer, for ease of use, the surface of the fully synthetic polyester can be marked to distinguish the front and back sides.

[0043] Example 2

[0044] Step 1: dissolve polylactic acid-glycolic acid copolymer (molecular weight 100000) in a solvent of ethyl acetate, dimethyltetrahydrofuran and acetone in a volume ratio of 1:1:2 to a concentration of 0.16 kg / L, stir and mix for later use;

[0045] Step 2: Polylactic acid-co-glycolic acid (molecular weight 100,000) and polycarboxylic acid synthetic rubber (molecular weight 100,000-300,000) are dissolved in a solution of methanol and dichloromethane in a volume ratio of 2:19, with concentrations of 0.16 kg / L and 0.12 kg / L, respectively, and stirred and mixed for later use;

[0046] Step 3: Before silicon coating, release paper made of antistatic agent printed pattern is used as the substrate, the solutions obtained in step 2 are respectively loaded into syringes, and capillaries are used to connect to the staggered needles, the polycarboxylic acid synthetic rubber push flow rate is 18mL / h, the polylactic acid-glycolic acid copolymer push flow rate is 24mL / h, an electric field voltage of -20-20kV is applied, and spinning is performed for 2min;

[0047] Step 4: Put the polylactic acid-co-glycolic acid solution obtained in step 1 into a syringe, connect it to the injection needle using a capillary, arrange the needles symmetrically in 4 groups, apply an electric field voltage of -20-20 kV at 20 mL / h, and spin for 20 minutes.

[0048] Step 5: Dry and cut the film to obtain the finished anti-adhesion film.

[0049] Example 3

[0050] Step 1: dissolve polylactic acid-co-glycolic acid (molecular weight 200000) in acetone at a concentration of 0.14 kg / L, stir and mix for later use;

[0051] Step 2: Polylactic acid-co-glycolic acid (molecular weight 200,000) and polycarboxylic acid synthetic rubber (molecular weight 100,000-300,000) are dissolved in a solution of methanol and dichloromethane in a volume ratio of 2:19, with concentrations of 0.14 kg / L and 0.10 kg / L, respectively, and stirred and mixed for later use;

[0052] Step 3: Volume resistivity is 10 6 Ω·cm release paper was used as the substrate, and the solutions obtained in step 2 were respectively loaded into syringes, connected to the coaxial needles using capillaries, the polycarboxylic acid synthetic rubber pushing rate was 18 mL / h, and the polylactic acid-glycolic acid copolymer pushing rate was 24 mL / h, an electric field voltage of -20-20 kV was applied, and spinning was performed for 2 min;

[0053] Step 4: Put the polylactic acid-co-glycolic acid solution obtained in step 1 into a syringe, connect it to the injection needle using a capillary, arrange the needles symmetrically in 4 groups, apply an electric field voltage of -20-20 kV at 20 mL / h, and spin for 10 minutes.

[0054] Step 5: Dry and cut the film to obtain the finished anti-adhesion film.

[0055] Example 4

[0056] Step 1: dissolve polylactic acid-co-glycolic acid (molecular weight 200000) in acetone at a concentration of 0.14 kg / L, stir and mix for later use;

[0057] Step 2: Polylactic acid-co-glycolic acid (molecular weight 200,000) and polycarboxylic acid synthetic rubber (molecular weight 100,000-300,000) are dissolved in a solution of methanol and dichloromethane in a volume ratio of 2:19, with concentrations of 0.14 kg / L and 0.10 kg / L, respectively, and stirred and mixed for later use;

[0058] Step 3: Using conventional release paper as the substrate, the solutions obtained in step 2 were respectively loaded into syringes and connected to the staggered needles using capillaries. The polycarboxylic acid synthetic rubber was pushed at a flow rate of 18 mL / h, and the polylactic acid-glycolic acid copolymer was pushed at a flow rate of 24 mL / h. An electric field voltage of -20-20 kV was applied and spinning was performed for 2 minutes.

[0059] Step 4: Put the polylactic acid-co-glycolic acid solution obtained in step 1 into a syringe, connect it to the injection needle using a capillary, arrange the needles symmetrically in 4 groups, apply an electric field voltage of -20-20 kV at 20 mL / h, and spin for 20 minutes.

[0060] Step 5: Dry and cut the film.

[0061] Example 5

[0062] Step 1: dissolve polylactic acid (molecular weight 80000) in acetone at a concentration of 0.14 kg / L, stir and mix for later use;

[0063] Step 2: Polylactic acid (molecular weight 80,000) and polycarboxylic acid synthetic rubber (molecular weight 100,000-300,000) are dissolved in acetone and dichloromethane solution with a volume ratio of 2:19, with concentrations of 0.14 kg / L and 0.10 kg / L respectively, and stirred and mixed for later use;

[0064] Step 3: Volume resistivity is 10 6 Ω·cm release paper was used as the substrate, and the solutions obtained in step 2 were respectively loaded into syringes and connected to the staggered needles using capillaries. The polycarboxylic acid synthetic rubber pushing flow rate was 18 mL / h, and the polylactic acid pushing flow rate was 24 mL / h. An electric field voltage of -20-20 kV was applied and spinning was performed for 2 min.

[0065] Step 4: The polymer solution obtained in step 1 was placed in a syringe and connected to the injection needle using a capillary. The needles were arranged symmetrically in 4 groups. An electric field voltage of -20-20 kV was applied at 20 mL / h for spinning for 10 min.

[0066] Step 5: Dry and cut the film to obtain the finished anti-adhesion film.

[0067] Example 6

[0068] Step 1: dissolving polylactic acid (molecular weight 80,000) and polylactic acid-glycolic acid copolymer (molecular weight 100,000) in a solvent of dimethyl carbonate, methyl acetate and acetone in a volume ratio of 1:1:2 at a mass ratio of 0.5:1-2 to a concentration of 0.16 kg / L, stirring and mixing for later use;

[0069] Step 2: polylactic acid (molecular weight 80000) and polylactic acid-glycolic acid copolymer (molecular weight 100000) are dissolved in a mass ratio of 0.5:1-2, and polycarboxylic acid synthetic rubber (molecular weight 100000-300000) are dissolved in a volume ratio of acetone and dichloromethane 2:19 solution, and the concentrations are 0.14kg / L and 0.10kg / L respectively, and stirred and mixed for use;

[0070] Step 3: Use conventional release paper as the receiving substrate to load the solutions obtained in step 2 into syringes respectively, use capillaries to connect to the staggered needles, push the polycarboxylic acid synthetic rubber at a flow rate of 18 mL / h, and push the polylactic acid and polylactic acid-glycolic acid copolymer solution at a flow rate of 24 mL / h, apply an electric field voltage of -20-20 kV, and spin for 2 minutes.

[0071] Step 4: The polymer solution obtained in step 1 was placed in a syringe and connected to the injection needle using a capillary. The needles were arranged symmetrically in 4 groups. An electric field voltage of -20-20 kV was applied at 20 mL / h for spinning for 10 min.

[0072] Step 5: Dry and cut the film to obtain the finished anti-adhesion film.

[0073] Examples 1-6 Characterization and performance testing

[0074] 1. The thickness, pore size, porosity and tensile strength of the films cut from Examples 1 to 6 were measured respectively, as shown in the following table:

[0075]

[0076] 2. In vitro degradation performance test

[0077] The in vitro degradation performance was tested with pH 7.4 phosphate buffer, and the samples were continuously shaken at 37°C in a constant temperature shaker. After 14 days, the overall structure of Example 4 was intact, but some flocculent structures appeared around it. Examples 1-3 and Examples 5 and 6 all retained intact structures. After 28 days, the membrane of Example 4 was broken, while the structures of Examples 1-3 and Examples 5 and 6 were intact, with a small amount of flocculent. This shows that the different solvent combinations used in the PLA or PLGA solutions used in the barrier layer of Examples 1, 2, and 6, and the volume resistivity of Examples 3 and 5 is 10 6Ω·cm release paper is used as the substrate to achieve a dense structure. The electrospinning membranes prepared in Examples 1-3 and Examples 5 and 6 have higher mechanical strength than that prepared in Example 4. Their complete structures are retained in the body for a longer time than that in Example 4. The average pore size is between 10-50 μm, which can well prevent blood vessel growth and does not hinder the transmission of nutrients.

[0078] 3. Adhesion performance test

[0079] The anti-adhesion films obtained in Examples 1, 2, 3, 5 and 6 were adhered to the casings and immersed in a bottle containing pH 7.4 phosphate buffer, and continuously shaken at 37° C. in a constant temperature shaking box. After one week, the films were still attached to the casings, indicating that the anti-adhesion film of the present application can obtain a longer initial adhesion, which greatly reduces the influence of film movement and dislocation on the anti-adhesion effect.

[0080] The anti-adhesion membranes obtained in Examples 1, 2, 3, 5 and 6 were tested for adhesion using sausage casings as substrates, and the test results were between 600 and 800 gf, indicating that the anti-adhesion membranes of the present application have good adhesion.

[0081] The anti-adhesion membrane with a dense structure in the present application avoids the existing polysaccharide materials with tissue adhesion properties, which degrade too quickly and cause adverse reactions such as allergies, and can exist intact in the area where anti-adhesion is required for a longer period of time. The anti-adhesion mechanism of the anti-adhesion membrane is to prevent blood vessels from growing in to avoid the formation of permanent adhesions such as scar tissue that it promotes; the preparation process of the dense structure film provided by the present invention realizes the characteristics of the dense structure and porous structure of the barrier layer and the excellent adhesion performance of the adhesive layer.

[0082] The above embodiments are only used to illustrate the present invention, rather than to limit the present invention. Those skilled in the relevant technical field may make various changes or modifications without departing from the spirit and scope of the present invention. Therefore, all equivalent technical solutions should also belong to the scope of the present invention and should be defined by the claims.

Claims

1. A bondable anti-adhesion film, characterized in that: A composite structure consisting of an adhesive layer and a barrier layer, wherein the adhesive layer is formed by blending or coaxial electrospinning of a fully synthetic adhesive and a fully synthetic polyester, and the barrier layer is formed by electrospinning of a fully synthetic polyester; The fully synthetic polyester is at least one of polylactic acid PLA and polylactic acid-glycolic acid copolymer PLGA, and the fully synthetic adhesive is polycarboxylic acid synthetic adhesive.

2. A bondable anti-adhesion film according to claim 1, characterized in that: The thickness of the adhesive anti-adhesion film is 0.04-0.15 mm, and the average pore size is 10-50 μm, wherein the thickness of the adhesive layer is 0.001-0.05 mm, the mass ratio of the fully synthetic adhesive to the fully synthetic polyester is 1:5-40, and the shear bonding force of the adhesive layer is greater than 300 gf.

3. A method for preparing the adhesive anti-adhesion film according to claim 1 or 2, characterized in that: The following steps are included: (1) mixing the first solvent with the fully synthetic polyester to obtain a fully synthetic polyester solution with a concentration of 0.12-0.24 kg / L; (2) mixing the second solvent with the fully synthetic adhesive and the fully synthetic polyester, respectively, to obtain a fully synthetic adhesive solution with a concentration of 0.06-0.12 kg / L and a fully synthetic polyester solution with a concentration of 0.12-0.24 kg / L; (3) electrospinning the fully synthetic adhesive solution prepared in step (2) and the fully synthetic polyester solution onto a receiving substrate in a blended or coaxial form to form an adhesive layer; (4) spinning the fully synthetic polyester solution prepared in step (1) onto the adhesive layer by electrospinning to form a barrier layer, thereby obtaining an adhesive anti-adhesion film; Wherein, when the first solvent in step (1) is a single solvent, the volume resistivity of the receiving substrate in step (3) is less than 10 12 Ω·cm.

4. The method for preparing the adhesive anti-adhesion film according to claim 3, characterized in that: The first solvent is at least one of methyl formate, ethyl acetate, methyl acetate, dimethyl carbonate, dimethyltetrahydrofuran, acetone, and methanol.

5. The method for preparing the adhesive anti-adhesion film according to claim 3, characterized in that: The second solvent is a mixed solvent formed by the mutual dissolution of any one of methanol and acetone with dichloromethane in a volume ratio of 2:17-21.

6. The method for preparing the adhesive anti-adhesion film according to claim 3, characterized in that: In the electrospinning step described in step (3), the flow rate of the fully synthetic adhesive solution is 15-40 mL / h, the flow rate of the fully synthetic polyester solution is 5-30 mL / h, an electric field voltage of -20-20 kV is applied, and the spinning is performed for 1-10 minutes.

7. The method for preparing the adhesive anti-adhesion film according to claim 3, characterized in that: In the electrostatic spinning step described in step (4), the fully synthetic polyester solution has a push flow rate of 10-40 mL / h, an electric field voltage of -20-20 kV is applied, and the spinning is performed for 5-40 minutes.

Citation Information

Patent Citations

  • Electrostatic spinning polymer anti-adhesion fibrous membrane with excellent flexibility

    CN102908658A

  • Hemostatic anti-adhesion film and preparation method thereof

    CN106730047A